Tenecteplase in Acute Stroke: What About the Children?

Area of Science:

• Neurology
• Pediatric Stroke
• Pharmacology

Background:

• Tenecteplase is increasingly used for adult ischemic stroke management, offering practical and pharmacokinetic benefits over alteplase.
• Thrombolytic therapy use is rising in childhood stroke, but tenecteplase experience in pediatric populations is limited.
• No data currently exist on the safety, dosing, or efficacy of tenecteplase for acute childhood stroke.

Purpose of the Study:

• To highlight the limited data on tenecteplase use in pediatric stroke.
• To identify factors influencing the transition from alteplase to tenecteplase in acute pediatric stroke treatment.
• To emphasize the need for guideline development and prospective data collection in pediatric stroke management.

Main Methods:

• Literature review on tenecteplase and alteplase in stroke management.
• Analysis of pediatric-specific pharmacological considerations for fibrinolytic agents.
• Discussion of practical aspects of drug delivery in pediatric care settings.

Main Results:

• Tenecteplase has demonstrated advantages in adult stroke care, but its pediatric application remains unstudied.
• Pediatric factors like age-specific drug clearance and hospital availability may affect tenecteplase adoption.
• Significant knowledge gaps exist regarding tenecteplase's role in treating childhood stroke.

Conclusions:

• Transitioning to tenecteplase for acute pediatric stroke requires careful consideration of safety, dosing, and efficacy.
• Pediatric neurologists must develop institution-specific guidelines for tenecteplase use.
• Prospective data collection is crucial to establish tenecteplase's role in pediatric stroke management.